Systemic complement activation levels in Stargardt disease

PURPOSE: Preclinical research provides evidence for the complement system as a potential common pathway in Stargardt disease (STGD1) and age-related macular degeneration (AMD) leading to retinal pigment epithelium (RPE) loss. However, systemic complement activation has not yet been assessed in STGD1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Dhooge, Patty P. A., Runhart, Esmee H., Li, Catherina H. Z., de Kat Angelino, Corrie M., Hoyng, Carel B., van der Molen, Renate G., den Hollander, Anneke I.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8232401/
https://ncbi.nlm.nih.gov/pubmed/34170959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0253716
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados